Search This Site:
Clinical Commissioning Groups Logo

Prescribing Information & Guidance

Bulletin 272 Gender Identity Services – Primary Care Prescribing Responsibilities for the Hormonal Treatments (including Eflornithine for the Treatment of Hirsutism in this setting) – JPC Position Statement

Guideline added to website on: 26/02/19
Last modified on: 27/10/20
CCG: |
Tags: eflornithine, gender, hirsutism, hormonal, hormone, identity, transgender

Posted in
Scroll to Top